Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Rhythm Biosciences.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: From feather duster to rooster, Nanosonics again rules the roost
Health & Biotech
Rhythm hits 2024 key milestones, targets 2025 launch of next-gen bowel cancer test
Health & Biotech
Health Check: Approval clock ticks as FDA accepts Telix’s brain diagnostic marketing application
News
ASX Small Caps Lunch Wrap: No rest for ASX on Labour Day as benchmark inches higher
Health & Biotech
National biotech summit shows off a wealth of healthcare and medical innovation
News
Rise and Shine: Everything you need to know before the ASX opens
News
In Case You Missed It: A Medicare win and director resignations round out the year
News
Top 10 at 11: Hefty moves by some hefty companies are making waves this morning
Health & Biotech
ASX Health Stocks: Rhythm Bio says new research in lung cancer is warranted after this finding
News
Rise and Shine: Everything you need to know before the ASX opens
Explainers
ASX cancer stocks guide: Here’s everything you need to know
News
ASX Small Caps and Weekly IPO Wrap: Tech, Telcos and Money do well in a positive week overall
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: Hump Day is Slump Day yet again, as the ASX drops another 0.46%
News
In Case You Missed It: Cancer fighters, Kalahari copper and corporate travel on the rise
News
ASX Small Caps Lunch Wrap: Who else is probably going to regret the jokes they told this morning?
Health & Biotech
